181 related articles for article (PubMed ID: 12739991)
1. Direct thrombin inhibitors.
Kaplan KL
Expert Opin Pharmacother; 2003 May; 4(5):653-66. PubMed ID: 12739991
[TBL] [Abstract][Full Text] [Related]
2. Direct thrombin inhibitors.
Kaplan KL; Francis CW
Semin Hematol; 2002 Jul; 39(3):187-96. PubMed ID: 12124681
[TBL] [Abstract][Full Text] [Related]
3. Novel uses for current and future direct thrombin inhibitors: focus on ximelagatran and bivalirudin.
Kalus JS; Caron MF
Expert Opin Investig Drugs; 2004 May; 13(5):465-77. PubMed ID: 15155122
[TBL] [Abstract][Full Text] [Related]
4. New developments in parenteral anticoagulation for arterial and venous thromboembolism.
van Es N; Bleker SM; Büller HR; Coppens M
Best Pract Res Clin Haematol; 2013 Jun; 26(2):203-13. PubMed ID: 23953908
[TBL] [Abstract][Full Text] [Related]
5. Bivalent direct thrombin inhibitors: hirudin and bivalirudin.
Warkentin TE
Best Pract Res Clin Haematol; 2004 Mar; 17(1):105-25. PubMed ID: 15171961
[TBL] [Abstract][Full Text] [Related]
6. Direct thrombin inhibitors in cardiac disease.
Weitz JI; Bates ER
Cardiovasc Toxicol; 2003; 3(1):13-25. PubMed ID: 12668887
[TBL] [Abstract][Full Text] [Related]
7. Effects of pentasaccharide (fondaparinux) and direct thrombin inhibitors on coagulation testing.
Gosselin RC; King JH; Janatpur KA; Dager WH; Larkin EC; Owings JT
Arch Pathol Lab Med; 2004 Oct; 128(10):1142-5. PubMed ID: 15387708
[TBL] [Abstract][Full Text] [Related]
8. Direct thrombin inhibitors.
Lee CJ; Ansell JE
Br J Clin Pharmacol; 2011 Oct; 72(4):581-92. PubMed ID: 21241354
[TBL] [Abstract][Full Text] [Related]
9. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.
Nielsen VG; Steenwyk BL; Gurley WQ; Pereira SJ; Lell WA; Kirklin JK
J Heart Lung Transplant; 2006 Jun; 25(6):653-63. PubMed ID: 16730571
[TBL] [Abstract][Full Text] [Related]
10. Effect of direct thrombin inhibitors, bivalirudin, lepirudin, and argatroban, on prothrombin time and INR values.
Gosselin RC; Dager WE; King JH; Janatpour K; Mahackian K; Larkin EC; Owings JT
Am J Clin Pathol; 2004 Apr; 121(4):593-9. PubMed ID: 15080313
[TBL] [Abstract][Full Text] [Related]
11. Molecular approaches to antithrombotic therapy.
Scharfstein J; Loscalzo J
Hosp Pract (Off Ed); 1992 May; 27(5):77-86. PubMed ID: 1577892
[TBL] [Abstract][Full Text] [Related]
12. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
[TBL] [Abstract][Full Text] [Related]
13. Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation.
Warkentin TE; Greinacher A; Craven S; Dewar L; Sheppard JA; Ofosu FA
Thromb Haemost; 2005 Nov; 94(5):958-64. PubMed ID: 16363236
[TBL] [Abstract][Full Text] [Related]
14. Bivalirudin: a review of the pharmacology and clinical application.
Van De Car DA; Rao SV; Ohman EM
Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1673-81. PubMed ID: 21108549
[TBL] [Abstract][Full Text] [Related]
15. The evolving role of direct thrombin inhibitors in acute coronary syndromes.
Eikelboom J; White H; Yusuf S
J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):70S-78S. PubMed ID: 12644344
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of bivalirudin.
Reed MD; Bell D
Pharmacotherapy; 2002 Jun; 22(6 Pt 2):105S-111S. PubMed ID: 12064567
[TBL] [Abstract][Full Text] [Related]
17. Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors.
Gurm HS; Bhatt DL
Am Heart J; 2005 Jan; 149(1 Suppl):S43-53. PubMed ID: 15644793
[No Abstract] [Full Text] [Related]
18. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.
Chew DP
Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763
[TBL] [Abstract][Full Text] [Related]
19. Thrombin-directed inhibitors: pharmacology and clinical use.
White CM
Am Heart J; 2005 Jan; 149(1 Suppl):S54-60. PubMed ID: 15644794
[No Abstract] [Full Text] [Related]
20. Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
Lewis BE; Hursting MJ
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):57-68. PubMed ID: 17187457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
